Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Labopharm completes South Korean licensing and distribution deal for Tramadol
“This agreement marks our first foray into Asia as we continue to establish sales channels in key markets around the world as part of the global commercialization program
“This agreement marks our first foray into Asia as we continue to establish sales channels in key markets around the world as part of the global commercialization program
The company said that, based on the current production schedule, which began on July 6, 2007, PurEffect infomercials will begin broadcasting in fall 2007. eFoodSafety.com expects sales revenue
TRC093 is a first-in-class humanized monoclonal antibody that inhibits angiogenesis and tumor cell growth by binding cleaved collagen, a component of the extracellular matrix of tumors that serves
Additionally, one-year survival rates were 74% for the ASA404 arm and 92% for the control arm. Since the majority of patients in both arms were alive after one
The Ventana board is now urging stockeholders not to tender any of their shares to Roche. The cancer diagnostics firm says it will “vigorously resist” Roche’s attempt to
Additionally, the drug reduced severe side effects like heart damage compared to a standard doxorubicin-based treatment. “We are excited by these results demonstrating that pixantrone is living up
The multi-center trial is expected to begin enrolling patients once the protocol regulatory review is completed. The trial has a two-stage design. Up to 21 NSCLC patients will
The primary objectives of the collaboration will be to develop models of resistance to Panzem (2ME2) in order to identify key proteins that may be potential novel drug
The agreement covers the Republic of Armenia, Georgia, and the Republic of Kazakhstan. ADA and CATH will bear any and all costs associated with the procurement of governmental
AMD currently affects approximately 10 million people in the US and is the leading cause of blindness in persons over age 65, according to an article published in